Belite Bio Prices $350 Million Equity Offering

MT Newswires Live
12/02

Belite Bio (BLTE) said Monday it has priced an underwritten public offering of about 2.3 million American depositary shares at $154 each.

The company said it has also granted underwriters a 30-day option to purchase up to 340,909 additional depositary shares.

The company said it expects gross proceeds of about $350 million from the offering, which is expected to close about Wednesday.

The company said it plans to use net proceeds of the offering for general corporate purposes.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10